Tumor necrosis factor receptor
From Proteopedia
(Difference between revisions)
Line 22: | Line 22: | ||
* '''TNFRSF 18''' is called '''GITRL''';<br /> | * '''TNFRSF 18''' is called '''GITRL''';<br /> | ||
* '''TNFRSF 21''' is called '''Dr6''';<br /> | * '''TNFRSF 21''' is called '''Dr6''';<br /> | ||
+ | * '''TNFRSF 25''' is called '''Dr3''';<br /> | ||
==See also [[Tumor necrosis factor ligand superfamily]]== | ==See also [[Tumor necrosis factor ligand superfamily]]== | ||
Line 29: | Line 30: | ||
== Structural highlights == | == Structural highlights == | ||
The extracellular domain of TNFR contains 2 to 6 cysteine-rich domains (CRD). The <scene name='59/590824/Cv/8'>CRD domains are ca. 40 amino-acid long and contain 4-6 cysteine residues</scene>. The CRDs are involved in binding of TNF<ref>PMID:8939750</ref>. <scene name='59/590824/Cv/9'>Mg coordination site</scene>. Water molecules are shown as red spheres. | The extracellular domain of TNFR contains 2 to 6 cysteine-rich domains (CRD). The <scene name='59/590824/Cv/8'>CRD domains are ca. 40 amino-acid long and contain 4-6 cysteine residues</scene>. The CRDs are involved in binding of TNF<ref>PMID:8939750</ref>. <scene name='59/590824/Cv/9'>Mg coordination site</scene>. Water molecules are shown as red spheres. | ||
+ | ==3D structures of tumor necrosis factor receptor== | ||
+ | [[Tumor necrosis factor receptor 3D structures]] | ||
+ | |||
</StructureSection> | </StructureSection> | ||
Line 58: | Line 62: | ||
*Tumor necrosis factor receptor superfamily-4 (OX40L receptor) | *Tumor necrosis factor receptor superfamily-4 (OX40L receptor) | ||
- | **[[2hew]] – mTNFSF-4 extracellular domain - mouse<BR /> | ||
**[[2hev]] – hTNFSF-4 extracellular domain + OX40 ligand<BR /> | **[[2hev]] – hTNFSF-4 extracellular domain + OX40 ligand<BR /> | ||
+ | **[[2hew]] – mTNFSF-4 extracellular domain - mouse<BR /> | ||
**[[2hey]] – mTNFSF-4 extracellular domain + hOX40 ligand<BR /> | **[[2hey]] – mTNFSF-4 extracellular domain + hOX40 ligand<BR /> | ||
Line 88: | Line 92: | ||
**[[5wi8]], [[5wjf]] – hTNFSF-9 extracellular domain<BR /> | **[[5wi8]], [[5wjf]] – hTNFSF-9 extracellular domain<BR /> | ||
**[[2x29]], [[5wiw]] – hTNFSF-9 extracellular domain (mutant)<BR /> | **[[2x29]], [[5wiw]] – hTNFSF-9 extracellular domain (mutant)<BR /> | ||
- | **[[6cu0]], [[6cpr]], [[6bnv]] – hTNFSF-9 extracellular domain (mutant) + | + | **[[6mkz]], [[6mgp]] – hTNFRSF-9 residues 24-160 + hTNFLS-9 residues 139-309<BR /> |
+ | **[[6cu0]], [[6cpr]], [[6bnv]], [[6bwv]] – hTNFSF-9 extracellular domain (mutant) + NSFLS9<BR /> | ||
+ | |||
+ | *Tumor necrosis factor receptor superfamily-10A | ||
+ | |||
+ | **[[5cir]] – hTNFSF-10A extracellular domain + hTNFLS-10 residues 114-281<BR /> | ||
*Tumor necrosis factor receptor superfamily-10B (Dr5) | *Tumor necrosis factor receptor superfamily-10B (Dr5) | ||
Line 97: | Line 106: | ||
**[[4i9x]] – hTNFRSF-10B extracellular domain + UL141<br /> | **[[4i9x]] – hTNFRSF-10B extracellular domain + UL141<br /> | ||
**[[4n90]] – hTNFRSF-10B + hTNFRSF-10 + antibody <br /> | **[[4n90]] – hTNFRSF-10B + hTNFRSF-10 + antibody <br /> | ||
+ | **[[6nhw]] – hTNFRSF-10B trasmembrane domain - NMR<br /> | ||
+ | **[[6nhy]] – hTNFRSF-10B trasmembrane domain (mutant) - NMR<br /> | ||
*Tumor necrosis factor receptor superfamily-11 | *Tumor necrosis factor receptor superfamily-11 | ||
+ | **[[3urf]] – hTNFSF-11 receptor-binding domain + osteoprotegerin<BR /> | ||
**[[1jtz]], [[1iqa]], [[1s55]] – mTNFSF-11 receptor-binding domain<BR /> | **[[1jtz]], [[1iqa]], [[1s55]] – mTNFSF-11 receptor-binding domain<BR /> | ||
**[[3me2]], [[3qbq]], [[4giq]] – mTNFSF-11 receptor-binding domain + RANK <BR /> | **[[3me2]], [[3qbq]], [[4giq]] – mTNFSF-11 receptor-binding domain + RANK <BR /> | ||
Line 137: | Line 149: | ||
*Tumor necrosis factor receptor superfamily-14 (LIGHT) | *Tumor necrosis factor receptor superfamily-14 (LIGHT) | ||
- | **[[4fhq]], [[4en0]] – hTNFRSF-14 extracellular domain <br /> | + | **[[4fhq]], [[4en0]], [[5t2r]], [[5t2q]] – hTNFRSF-14 extracellular domain <br /> |
**[[2aw2]] – hTNFRSF-14 extracellular domain + B and T lymphocyte attenuator <br /> | **[[2aw2]] – hTNFRSF-14 extracellular domain + B and T lymphocyte attenuator <br /> | ||
**[[4rsu]] – hTNFRSF-14 extracellular domain + TNFRSF-14 ligand<br /> | **[[4rsu]] – hTNFRSF-14 extracellular domain + TNFRSF-14 ligand<br /> | ||
Line 148: | Line 160: | ||
**[[4f42]], [[4f44]] – hTNFRSF-16 death domain<br /> | **[[4f42]], [[4f44]] – hTNFRSF-16 death domain<br /> | ||
**[[2n97]] – hTNFRSF-16 death domain - NMR<br /> | **[[2n97]] – hTNFRSF-16 death domain - NMR<br /> | ||
+ | **[[5zgg]] – hTNFRSF-16 transmembrane domain + pyridine derivative - NMR<br /> | ||
**[[2mic]] – rTNFRSF-16 transmembrane domain – rat - NMR<br /> | **[[2mic]] – rTNFRSF-16 transmembrane domain – rat - NMR<br /> | ||
**[[2mjo]] – rTNFRSF-16 transmembrane domain (mutant) - NMR<br /> | **[[2mjo]] – rTNFRSF-16 transmembrane domain (mutant) - NMR<br /> | ||
Line 163: | Line 176: | ||
*Tumor necrosis factor receptor superfamily-18 (GITRL) | *Tumor necrosis factor receptor superfamily-18 (GITRL) | ||
+ | **[[2q1m]], [[3b93]], [[3b94]] – hTNFRSF-18 extracellular domain <br /> | ||
+ | **[[2r30]], [[2r32]] – hTNFRSF-18 extracellular domain (mutant) <br /> | ||
**[[4db5]] – TNFRSF-18 – rabbit <br /> | **[[4db5]] – TNFRSF-18 – rabbit <br /> | ||
**[[4e4s]] – TNFRSF-18 – pika <br /> | **[[4e4s]] – TNFRSF-18 – pika <br /> | ||
**[[4g4f]] – TNFRSF-18 – bushbaby <br /> | **[[4g4f]] – TNFRSF-18 – bushbaby <br /> | ||
**[[3fc0]], [[2qdn]], [[3b9i]] – mTNFRSF-18 <br /> | **[[3fc0]], [[2qdn]], [[3b9i]] – mTNFRSF-18 <br /> | ||
- | **[[2q1m]], [[3b93]], [[3b94]] – hTNFRSF-18 extracellular domain <br /> | ||
- | **[[2r30]], [[2r32]] – hTNFRSF-18 extracellular domain (mutant) <br /> | ||
*Tumor necrosis factor receptor superfamily-21 (Dr6) | *Tumor necrosis factor receptor superfamily-21 (Dr6) | ||
Line 176: | Line 189: | ||
**[[3qo4]] – hTNFRSF-21 cysteine-rich domain<br /> | **[[3qo4]] – hTNFRSF-21 cysteine-rich domain<br /> | ||
**[[4yn0]] – hTNFRSF-21 cysteine-rich domain + amyloid beta A4 protein<br /> | **[[4yn0]] – hTNFRSF-21 cysteine-rich domain + amyloid beta A4 protein<br /> | ||
+ | |||
+ | *Tumor necrosis factor receptor superfamily-25 (Dr3) | ||
+ | |||
+ | **[[5ygs]] – hTNFRSF-25 death domain<br /> | ||
+ | **[[5ygp]] – hTNFRSF-25 death domain 9 (mutant)<br /> | ||
+ | **[[5yev]] – mTNFRSF-25 death domain<br /> | ||
+ | |||
}} | }} | ||
== References == | == References == |
Revision as of 10:27, 15 March 2020
|
3D structures of tumor necrosis factor receptor
Updated on 15-March-2020
References
- ↑ Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV, Boldin MP. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol. 1999;17:331-67. PMID:10358762 doi:http://dx.doi.org/10.1146/annurev.immunol.17.1.331
- ↑ Lopalco G, Rigante D, Vitale A, Frediani B, Iannone F, Cantarini L. Tumor necrosis factor receptor-associated periodic syndrome managed with the couple canakinumab-alendronate. Clin Rheumatol. 2015 Apr;34(4):807-9. doi: 10.1007/s10067-014-2556-8. Epub 2014, Mar 11. PMID:24609716 doi:http://dx.doi.org/10.1007/s10067-014-2556-8
- ↑ Naismith JH, Devine TQ, Kohno T, Sprang SR. Structures of the extracellular domain of the type I tumor necrosis factor receptor. Structure. 1996 Nov 15;4(11):1251-62. PMID:8939750